Send a Tweet
Most Popular Choices
Share on Facebook 13 Share on Twitter Printer Friendly Page More Sharing
Sci Tech   

WHO "Solidarity" and UK "Recovery" Clinical Trials of Hydroxychloroquine using Potentially Fatal Doses

Author 508740
Message Helen Carpenter
Become a Fan
  (6 fans)

This piece was reprinted by OpEdNews with permission or license. It may not be reproduced in any form without permission or license from the source.

By Meryl Nass, MD, writing in Age of Autism, a daily web newspaper:

'The Solidarity Trial  is a WHO-led conglomeration of many national trials of treatments for Covid-19. Per the WHO:

As of 3 June 2020, more than 3500 patients have been recruited in 35 countries, with over 400 hospitals actively recruiting patients. Overall, over 100 countries have joined or expressed an interest in joining the trial, and WHO is actively supporting 60 of them...

Last week, I was alerted to the fact that India's ICMR, its official medical research agency, had written to the WHO, telling WHO that the hydroxychloroquine doses being used in the Solidarity trial were 4 times higher than the doses being used in India.  Then I learned that Singapore had been hesitant to participate in the WHO trial due to the hydroxychloroquine dose.'


Read the rest of the story HERE:

At www.ageofautism.com

 

Must Read 2   Valuable 2   Well Said 1  
Rate It | View Ratings

Helen Carpenter Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in


As a young girl dining nightly to TV images of GI's dragging their buddies out of the rice paddies of Vietnam, this engendered a certain notion that somehow the world should be a better place. (more...)
 
Related Topic(s): ; , Add Tags
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: